CGS-CIMB Research retains Add for Duopharma, lower TP of RM1.90
KUALA LUMPUR: CGS-CIMB Equities Research is maintaining its Add call for Duopharma Biotech with a lower target price of RM1.90
Read moreKUALA LUMPUR: CGS-CIMB Equities Research is maintaining its Add call for Duopharma Biotech with a lower target price of RM1.90
Read more